Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platelet Transfusion Refractoriness”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)Ended earlyNCT05091684
What this trial is testing

Administration of Fibrinogen Concentrate for Refractory Bleeding

Who this might be right for
Hematological PatientsBleedingPlatelet Refractoriness
Centre Hospitalier Universitaire de Saint Etienne 1
Not applicableStudy completedNCT05399693
What this trial is testing

Platelet Transfusion Refractoriness

Who this might be right for
Platelet Transfusion Refractoriness
Institut de cancérologie Strasbourg Europe 50
Not applicableUnknownNCT05542134
What this trial is testing

Platelet Agregation in Patients on ECMO

Who this might be right for
Platelet Refractoriness
University Medical Centre Ljubljana 50
Early research (Phase 1)Looking for participantsNCT07072247
What this trial is testing

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Who this might be right for
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07635511
What this trial is testing

Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies

Who this might be right for
Hematological MalignanciesPlatelet Transfusion Refractoriness (PTR)HLA Antibodies
The First Affiliated Hospital of Soochow University 42
Not applicableUnknownNCT06325553
What this trial is testing

Incidence of Platelet Refractoriness in Adult Acute Leukemia Patients Receiving Prestorage Filtered Blood and Comparing With Historical Control

Who this might be right for
Platelet Refractoriness in Adult Acute Leukemia
Siriraj Hospital 252
Testing effectiveness (Phase 2)Looking for participantsNCT06792019
What this trial is testing

Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness

Who this might be right for
Platelet Transfusion Refractoriness
Keymed Biosciences Co.Ltd 110
Early research (Phase 1)Study completedNCT05832216
What this trial is testing

Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia

Who this might be right for
Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableStudy completedNCT03408158
What this trial is testing

HPA Antibodies and the Distribution of Antigen and Antibodies

Who this might be right for
Blood DiseasePlatelet RefractorinessAntibody-mediated Rejection
Guangzhou First People's Hospital 6,170
Not applicableUnknownNCT03679858
What this trial is testing

Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls

Who this might be right for
Cerebrovascular DisordersPlatelet RefractorinessPlatelet Aggregation, Spontaneous
University of Pecs 100
Testing effectiveness (Phase 2)Ended earlyNCT04631211
What this trial is testing

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Who this might be right for
ThrombocytopeniaHematologic MalignancyBone Marrow Aplasia+3 more
Cellphire Therapeutics, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT03712618
What this trial is testing

The SOLID Platelet Study

Who this might be right for
Platelet Transfusion Refractoriness (PTR)Thrombocytopenia
National Institutes of Health Clinical Center (CC) 2
Very early researchEnded earlyNCT05284032
What this trial is testing

A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)

Who this might be right for
Platelet RefractorinessHematologic Malignancy
Firas El Chaer, MD 3
Not applicableStudy completedNCT02858323
What this trial is testing

Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion

Who this might be right for
ThrombocytopeniaPlatelet Transfusion Refractoriness
National Institutes of Health Clinical Center (CC) 68
Testing effectiveness (Phase 2)Looking for participantsNCT06254560
What this trial is testing

Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

Who this might be right for
Severe Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT05761457
What this trial is testing

Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR

Who this might be right for
Platelet Transfusion Refractoriness
The First Affiliated Hospital of Soochow University 25
Testing effectiveness (Phase 2)UnknownNCT04846439
What this trial is testing

Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

Who this might be right for
Platelet Transfusion RefractorinessAcute Leukemia in Remission
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT02298933
What this trial is testing

Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia

Who this might be right for
ThrombocytopeniaAlloimmune Platelet Refractoriness
National Heart, Lung, and Blood Institute (NHLBI) 10